Form 4: iRhythm Technologies Chief Accounting Officer Reports Routine Stock Transactions

iRhythm Technologies' Chief Accounting Officer, Marc W. Rosenbaum, reported the acquisition of shares through an employee stock purchase plan and the subsequent sale of shares to cover tax obligations related to restricted stock unit vesting.

Summary

• Marc W. Rosenbaum, Chief Accounting Officer of iRhythm Technologies, Inc. (IRTC), filed a Form 4 statement detailing recent stock transactions.
• On May 30, 2025, Mr. Rosenbaum acquired 294 shares of iRhythm Technologies common stock at a price of $71.46 per share.
• This acquisition was made pursuant to the Issuer's 2016 Employee Stock Purchase Plan (ESPP) for the purchase period from December 1, 2024, through May 31, 2025, and is exempt from Section 16(b) under Rule 16b-3.
• On June 2, 2025, Mr. Rosenbaum disposed of 696 shares of common stock at a price of $140.21 per share.
• These shares were sold specifically to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units.
• Following these reported transactions, Mr. Rosenbaum's direct beneficial ownership of iRhythm Technologies common stock stands at 11,105 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine Form 4 filing detailing standard insider transactions related to compensation (ESPP acquisition and tax-related RSU sale), which typically do not indicate significant positive or negative company developments.

Positives

• The acquisition of 294 shares through the Employee Stock Purchase Plan indicates continued participation by a key executive in the company's equity programs, aligning management interests with shareholders.

Negatives

• The disposition of 696 shares, although for tax purposes related to RSU vesting, represents a reduction in the Chief Accounting Officer's direct shareholding.

Future Outlook

This Form 4 filing reports past insider transactions and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a routine disclosure of an insider's stock transactions and does not provide broader industry context or trends. It reflects standard compensation practices within publicly traded companies, particularly in the medical technology sector where iRhythm Technologies operates.

Stakeholder Impact

• Shareholders: The transactions are routine and related to executive compensation, with minimal direct impact on the broader shareholder base. The sale for tax purposes is a common occurrence for executives receiving equity compensation.
• Employees: The ESPP acquisition highlights the company's employee stock purchase program, which can be a positive for employee alignment and retention.

Key Dates

Keywords

iRhythm Technologies, IRTC, Form 4, Insider Transaction, Marc Rosenbaum, Chief Accounting Officer, Employee Stock Purchase Plan, Restricted Stock Units, Stock Sale, Tax Withholding